Literature DB >> 21641361

Institutional, provider, and patient correlates of low-density lipoprotein and non-high-density lipoprotein cholesterol goal attainment according to the Adult Treatment Panel III guidelines.

Salim S Virani1, Lechauncy D Woodard, Cassie R Landrum, Kenneth Pietz, Degang Wang, Christie M Ballantyne, Laura A Petersen.   

Abstract

BACKGROUND: The aim of this analysis was to identify the proportion of coronary heart disease (CHD) patients achieving guideline-recommended low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol (non-HDL-C) goals and to identify correlates of dual goal attainment.
METHODS: We analyzed patient, provider, and facility characteristics for 21,801 CHD patients in one Veterans Affairs Hospitals Network.
RESULTS: Low-density lipoprotein cholesterol goal attainment was 80%, but optional LDL-C goal attainment was 41%. Of patients with triglycerides ≥200 mg/dL, 51% attained both LDL-C and non-HDL-C goals. Correlates of higher dual goal attainment included older age (65-74 years: odds ratio [OR] 1.47, 95% CI 1.28-1.69), diabetes (OR 1.33, 95% CI 1.16-1.53), obesity (OR 1.25, 95% CI 1.04-1.50), a higher number of primary care visits (OR 1.04, 95% CI 1.04-1.05), and mild increase in illness severity of patients in provider's panel (OR 1.20, 95% CI 1.0008-1.46), whereas African American patients were less likely to achieve dual lipid goals (OR 0.63, 95% CI 0.48-0.82). Receipt of care from physician (vs nonphysician) or specialist (vs primary care) provider, number of patients in provider's panel, and percentage of patients in provider's panel with diagnosis of hyperlipidemia were not associated with dual goal attainment.
CONCLUSIONS: A large proportion of CHD patients attained LDL-C goal, but optional LDL-C goal attainment was low. Patients with elevated triglycerides had poor attainment of dual LDL-C and non-HDL-C goals, suggesting a treatment gap. Factors associated with dual goal attainment may identify interventions needed to improve future guideline adherence.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21641361     DOI: 10.1016/j.ahj.2011.03.023

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  Implementation strategies to improve non-HDL-cholesterol goal attainment: current evidence and a conceptual framework for future directions.

Authors:  Salim S Virani
Journal:  Tex Heart Inst J       Date:  2012

2.  Non-HDL cholesterol as a metric of good quality of care: opportunities and challenges.

Authors:  Salim S Virani
Journal:  Tex Heart Inst J       Date:  2011

3.  Regional variations in ambulatory care and incidence of cardiovascular events.

Authors:  Jack V Tu; Anna Chu; Laura Maclagan; Peter C Austin; Sharon Johnston; Dennis T Ko; Ingrid Cheung; Clare L Atzema; Gillian L Booth; R Sacha Bhatia; Douglas S Lee; Cynthia A Jackevicius; Moira K Kapral; Karen Tu; Harindra C Wijeysundera; David A Alter; Jacob A Udell; Douglas G Manuel; Prosanta Mondal; William Hogg
Journal:  CMAJ       Date:  2017-04-03       Impact factor: 8.262

4.  Prevalence of mixed dyslipidemia among Australian patients undergoing lipid-modifying therapy.

Authors:  David Colquhoun; Diana Chirovsky; Valsilisa Sazonov; Yadong A Cui; Baishali Ambegaonkar
Journal:  Exp Clin Cardiol       Date:  2013

5.  Effects of inadequate coverage on healthcare utilization: A regression discontinuity analysis.

Authors:  Jerome A Dugan; Layla G Booshehri
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

6.  Differences in statin usage and target-goal achievement between departments at the same hospital.

Authors:  Zhong Chen; Xin Wang; Zhen Ding; Peiying Fan; Genshan Ma
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

7.  Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis.

Authors:  Peter H Jones; Radhika Nair; Kamlesh M Thakker
Journal:  J Am Heart Assoc       Date:  2012-12-19       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.